Alert: Injectable Sodium Bicarbonate Shortage and Recall
Published June 21, 2017, 4:48 p.m.
Health Canada has issued an alert regarding a current shortage of injectable sodium bicarbonate product in Canada. Additionally, Pfizer, the product manufacturer, voluntarily recalled two lots of Sodium Bicarbonate Injection USP on June 14, 2017.
Pfizer has issued an availability update memo to remind customers to restrict inventory and orders to life-saving procedures and critical emergency use only, and to provide an update on estimated availability.
In Ontario, the Ministry of Health and Long Term Care is activating the Ministry's Emergency Operations Centres (MEOC) in order to provide a single point of contact and coordination for the provincial health system. Health system partners may direct questions, concerns or significant impacts to MEOC’s Health Care Provider Hotline at 1-866-212-2272 or firstname.lastname@example.org.
The Ontario Poison Centre (OPC) has issued recommendations for alternative treatments meant to augment the treatment advice provided by the OPC, but should not replace a consult call.